- Home page
- >
- Current issue
2023, volume 39, issue 2
Original article
Retrospective analysis of electroconvulsive therapy in treatment-resistant schizophrenia
Maria Chłopocka-Woźniak, Janusz Rybakowski, Filip Rybakowski, Maciej Malewski, Magda K. Malewska-Kasprzak
Farmakoterapia w Psychiatrii i Neurologii 2023, 39 (2), 95–102
Review article
Lithium in mood disorders – an update
Janusz Rybakowski
Farmakoterapia w Psychiatrii i Neurologii 2023, 39 (2), 103–113
Review article
Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders
Jakub Schimmelpfennig, Kamila Jankowiak-Siuda
Farmakoterapia w Psychiatrii i Neurologii 2023, 39 (2), 115–130
Review article
MDMA-assisted psychotherapy in the treatment of PTSD in adults – literature review
Monika Nowak, Julia Górczyńska, Michał Gebuza
Farmakoterapia w Psychiatrii i Neurologii 2023, 39 (2), 131–142
Review article
Importance of genotyping and phenotyping of CYP450 isoenzymes in the treatment of psychiatric disorders
Paweł Mierzejewski, Julita Kuczyńska, Julita Socha
Farmakoterapia w Psychiatrii i Neurologii 2023, 39 (2), 143–168
Review article
Postpartum psychosis with particular emphasis on its treatment
Ewa Kurczewska, Anna Konopka, Jagoda Kaczmarek, Sylwia Serbin, Weronika Kulma, Wiktoria Bossy
Farmakoterapia w Psychiatrii i Neurologii 2023, 39 (2), 169–185